16 Amici Support Sanofi In High Court Genus Patent Claims Enablement Row
WASHINGTON, D.C. — Fellow pharmaceutical firms, professors and intellectual property organizations are among those that filed amicus curiae briefs in the U.S. Supreme Court supporting Sanofi in its dispute with Amgen...To view the full article, register now.
Already a subscriber? Click here to view full article